Routes and schedules for treating multiple sclerosis with anti-CD52 antibodies Grant JP-7219721-B2 Japan 08 Feb 2023
ROUTES AND SCHEDULES FOR TREATING MULTIPLE SCLEROSIS WITH ANTI-CD52 ANTIBODIES Application WO-2018195457-A3 World Intellectual Property Organisation (WIPO) 29 Nov 2018